In 8 of the 627 patients, glucocerebrosidase activity was reduced and one homozygous causative mutation or two biallelic causative mutations confirmed the initial clinical suspicion of Gaucher disease (Table 2 and Table 3). This evidence concerns the gene GBA1 and Gaucher disease.